Literature DB >> 25640478

Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease.

Yan Gao1, Shi-feng Chu1, Jian-ping Li1, Zhao Zhang1, Jia-qing Yan1, Zhi-lin Wen2, Cong-yuan Xia1, Zheng Mou1, Zhen-zhen Wang1, Wen-bin He3, Xiao-feng Guo2, Gui-ning Wei4, Nai-hong Chen1.   

Abstract

AIM: Protopanaxtriol (Ppt) is extracted from Panax ginseng Mayer. In the present study, we investigated whether Ppt could protect against 3-nitropropionic acid (3-NP)-induced oxidative stress in a rat model of Huntington's disease (HD) and explored the mechanisms of action.
METHODS: Male SD rats were treated with 3-NP (20 mg/kg on d 1, and 15 mg/kg on d 2-5, ip). The rats received Ppt (5, 10, and 20 mg/kg, po) daily prior to 3-NP administration. Nimodipine (12 mg/kg, po) or N-acetyl cysteine (NAC, 100 mg/kg, po) was used as positive control drugs. The body weight and behavior were monitored within 5 d. Then the animals were sacrificed, neuronal damage in striatum was estimated using Nissl staining. Hsp70 expression was detected with immunohistochemistry. Reactive oxygen species (ROS) generation was measured using dihydroethidium (DHE) staining. The levels of components in the Nrf2 pathway were measured with immunohistochemistry and Western blotting.
RESULTS: 3-NP resulted in a marked reduction in the body weight and locomotion activity accompanied by progressive striatal dysfunction. In striatum, 3-NP caused ROS generation mainly in neurons rather than in astrocytes and induced Hsp70 expression. Administration of Ppt significantly alleviated 3-NP-induced changes of body weight and behavior, decreased ROS production and restored antioxidant enzymes activities in striatum. Moreover, Ppt directly scavenged free radicals, increased Nrf2 entering nucleus, and the expression of its downstream products heme oxygenase-1 (HO-1) and NAD(P)H quinone oxidase 1 (NQO1) in striatum. Similar effects were obtained with the positive control drugs nimodipine or NAC.
CONCLUSION: Ppt exerts a protective action against 3-NP-induced oxidative stress in the rat model of HD, which is associated with its anti-oxidant activity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25640478      PMCID: PMC4349920          DOI: 10.1038/aps.2014.107

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  37 in total

1.  Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription.

Authors:  Marcus J Calkins; Rebekah J Jakel; Delinda A Johnson; Kaimin Chan; Yuet Wai Kan; Jeffrey A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

Review 2.  Keap1: one stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xL.

Authors:  Hui Tian; Baofu Zhang; JieHui Di; Guan Jiang; FeiFei Chen; HuiZhong Li; LianTao Li; DongSheng Pei; JunNian Zheng
Journal:  Cancer Lett       Date:  2012-06-26       Impact factor: 8.679

Review 3.  The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Gururaj Joshi; Jeffrey A Johnson
Journal:  Recent Pat CNS Drug Discov       Date:  2012-12

4.  Avian uncoupling protein expressed in yeast mitochondria prevents endogenous free radical damage.

Authors:  François Criscuolo; Maria del Mar Gonzalez-Barroso; Yvon Le Maho; Daniel Ricquier; Frederic Bouillaud
Journal:  Proc Biol Sci       Date:  2005-04-22       Impact factor: 5.349

Review 5.  Oxidative damage in Huntington's disease pathogenesis.

Authors:  Susan E Browne; M Flint Beal
Journal:  Antioxid Redox Signal       Date:  2006 Nov-Dec       Impact factor: 8.401

6.  Effect of exogenous and endogenous antioxidants on 3-nitropionic acid-induced in vivo oxidative stress and striatal lesions: insights into Huntington's disease.

Authors:  M A Fontaine; J W Geddes; A Banks; D A Butterfield
Journal:  J Neurochem       Date:  2000-10       Impact factor: 5.372

7.  A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities.

Authors:  Lichuan Yang; Noel Y Calingasan; Junyu Chen; James J Ley; David A Becker; M Flint Beal
Journal:  Exp Neurol       Date:  2005-01       Impact factor: 5.330

8.  Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis.

Authors:  Jong-Min Lee; Marcus J Calkins; Kaimin Chan; Yuet Wai Kan; Jeffrey A Johnson
Journal:  J Biol Chem       Date:  2003-01-28       Impact factor: 5.157

9.  Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease.

Authors:  Verónica Pérez-De La Cruz; Diana Elinos-Calderón; Yolanda Robledo-Arratia; Omar N Medina-Campos; José Pedraza-Chaverrí; Syed F Ali; Abel Santamaría
Journal:  Behav Brain Res       Date:  2008-11-30       Impact factor: 3.332

10.  Effects of Panax ginseng in Neurodegenerative Diseases.

Authors:  Ik-Hyun Cho
Journal:  J Ginseng Res       Date:  2012-10       Impact factor: 6.060

View more
  23 in total

1.  Mitochondrial retrograde signalling in neurological disease.

Authors:  Lucy Granat; Rachel J Hunt; Joseph M Bateman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-05-04       Impact factor: 6.237

2.  Ursodeoxycholic acid as a potential alternative therapeutic approach for neurodegenerative disorders: Effects on cell apoptosis, oxidative stress and inflammation in the brain.

Authors:  Fei Huang
Journal:  Brain Behav Immun Health       Date:  2021-09-21

Review 3.  GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders.

Authors:  Divya Soni; Puneet Kumar
Journal:  Pharmacol Rep       Date:  2022-07-26       Impact factor: 3.919

4.  Restoration of BDNF, DARPP32, and D2R Expression Following Intravenous Infusion of Human Immature Dental Pulp Stem Cells in Huntington's Disease 3-NP Rat Model.

Authors:  Cristiane Valverde Wenceslau; Dener Madeiro de Souza; Nicole Caroline Mambelli-Lisboa; Leandro Hideki Ynoue; Rodrigo Pinheiro Araldi; Joyce Macedo da Silva; Eduardo Pagani; Monica Santoro Haddad; Irina Kerkis
Journal:  Cells       Date:  2022-05-17       Impact factor: 7.666

5.  Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway.

Authors:  Kuo-Feng Hua; A-Ching Chao; Ting-Yu Lin; Wan-Tze Chen; Yu-Chieh Lee; Wan-Han Hsu; Sheau-Long Lee; Hsin-Min Wang; Ding-I Yang; Tz-Chuen Ju
Journal:  J Ginseng Res       Date:  2021-11-11       Impact factor: 5.735

6.  Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington's disease via suppressing MAPKs and NF-κB pathways in the striatum.

Authors:  Xiong Yang; Shi-Feng Chu; Zhen-Zhen Wang; Fang-Fang Li; Yu-He Yuan; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

Review 7.  Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Delinda A Johnson; Jeffrey A Johnson
Journal:  Free Radic Biol Med       Date:  2015-08-14       Impact factor: 7.376

8.  A new coumarin derivative, IMM-H004, attenuates okadaic acid-induced spatial memory impairment in rats.

Authors:  Xiu-yun Song; Ying-ying Wang; Shi-feng Chu; Jin-feng Hu; Peng-fei Yang; Wei Zuo; Lian-kun Song; Shuai Zhang; Nai-hong Chen
Journal:  Acta Pharmacol Sin       Date:  2016-02-01       Impact factor: 6.150

9.  Identification of cyclin D1 as a major modulator of 3-nitropropionic acid-induced striatal neurodegeneration.

Authors:  Paula Dietrich; Shanta Alli; Megan K Mulligan; Rachel Cox; David G Ashbrook; Robert W Williams; Ioannis Dragatsis
Journal:  Neurobiol Dis       Date:  2021-12-03       Impact factor: 5.996

Review 10.  Protective effects of ginseng on neurological disorders.

Authors:  Wei-Yi Ong; Tahira Farooqui; Hwee-Ling Koh; Akhlaq A Farooqui; Eng-Ang Ling
Journal:  Front Aging Neurosci       Date:  2015-07-16       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.